FDA Approved: COREG — Supplemental Application (Waylis Therapeutics LLC)

View source ↗

Summary

FDA approved a supplemental application for COREG (carvedilol) submitted by Waylis Therapeutics LLC, typically involving a label change or new indication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Hypertension
• Ischemic Heart Disease
• Left Ventricular Dysfunction After Myocardial Infarction

Drugs mentioned

• Coreg (carvedilol)

Snippet

SUPPL AP for COREG (CARVEDILOL)